AstraZeneca Pharma India slipped 1.07% to Rs 3,370 after the company's standalone net profit dropped 45.03% to Rs 10.24 crore on 9.38% decline in net sales to Rs 175.40 crore in Q1 June 2021 (Q1 FY22) over Q1 June 2020 (Q1 FY21).
Standalone profit before tax tumbled 48.82% to Rs 13.50 crore in Q1 FY22 as against Rs 26.38 crore in Q1 FY21. The Q1 result was declared during market hours today, 9 August 2021.
Meanwhile, the board has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22. It has fixed 20 August 2021 as the record date for determining the entitlement of the shareholders for the payment of interim dividend.
AstraZeneca Pharma India is a listed subsidiary of AstraZeneca Plc, UK. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app